Dow Down0.25% Nasdaq Down0.26%

More On JUBILANT.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Jubilant Life Sciences Limited (JUBILANT.NS)

-NSE
167.30 Down 3.05(1.79%) Aug 28, 5:59AM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Mar 31, 2013Mar 31, 2012Mar 31, 2011
Total Revenue 58,034,000   51,660,000   43,031,000   34,456,000  
Cost of Revenue32,558,000  27,768,000  22,606,000  18,741,000  
Gross Profit 25,475,000   23,892,000   20,426,000   15,715,000  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative -   -   -   -  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses50,547,000  43,459,000  36,188,000  30,423,000  
Operating Income or Loss 7,487,000   8,201,000   6,844,000   4,034,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes7,487,000  8,201,000  6,844,000  4,034,000  
Interest Expense(3,064,000)(2,848,000)(2,215,000)(1,081,000)
Income Before Tax -   -   -   -  
Income Tax Expense696,000  1,524,000  684,000  134,000  
Minority Interest(286,000)(361,000)(311,000)25,000  
Net Income From Continuing Ops1,376,000  1,888,000  457,000  2,272,000  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 1,090,000   1,527,000   146,000   2,297,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares -   -   -   -  

Currency in INR.